Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and young people under 17 years of age at the time of the last observation date (30 June 2021)
- People who were assessed in a clinic or hospital setting between 1 January 2018 and 30 June 2021 and received a diagnosis of Tuberous Sclerosis Complex (TSC), a genetic condition that causes non-cancerous growths to form in the brain and other organs
- People whose parent or legal guardian has signed a consent form agreeing to participation
Who may not be able to join:
- People who were older than 18 years of age at the time of the study
- People who have other phacomatoses, which are a group of genetic conditions that affect the skin, nervous system, and other organs (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andrea Pasini, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phone: 00390512144613
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Stage of angiomyolipoma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.